A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients

Phase 3 Not yet recruiting 396 enrolled Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase III, multicenter, randomized, double-masked, Active-controlled design. The aims to confirm previous findings of the efficacy and safety of CsA-PG Ophthalmic Gel by comparing it to CsA Ophthalmic Gel for treating dry eye symptoms.

Timeline

Start: 2025-05-20
Primary completion: 2025-10-20
Completion: 2025-11-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	CsA	Unknown	—	Other
Subject	CsA-PG	Unknown	—	Other

A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients

Summary

Timeline

Drugs

Indications